340B Program
About UCI Health
UCI Health serves a substantial population comprising nearly 4 million individuals in Orange County, western Riverside County and southeast Los Angeles County. As the sole academic health system in Orange County, UCI Health is committed to advancing medical knowledge, educating future healthcare professional, and delivering the highest-quality, evidence-based healthcare. The primary facility, UCI Medical Center in Orange, is a 450+ bed acute care hospital offering advanced tertiary and quaternary care services, as well as a range of ambulatory and specialty medical clinics, along with behavioral health and rehabilitation units. UCI Health is notable for being home to Orange County's only federally designated comprehensive cancer center, a specialized high-risk perinatal/neonatal program, and a verified Level I trauma center for adults and Level II trauma center for pediatric patients, in addition to being a regional burn center. It is also proud to have the county's inaugural Joint Commission-certified comprehensive stroke center.
UCI Health is eligible for participation in the U.S. government's 340B program, a program mandating pharmaceutical companies to offer outpatient drugs to eligible healthcare organizations at substantially reduced prices. This eligibility is based on its substantial service to low-income Medicare and Medicaid patients.
Given the absence of a county hospital, roughly 75% of the UCI Health patient base relies on government payers for insurance coverage. Notably, California possesses one of the nation's lowest Medicaid provider reimbursement rates, and the costs associated with specialty services often exceed the reimbursement received. Consequently, UCI Health bears the burden of uncompensated costs related to services in areas such as cancer care, trauma care, burn care, mental health services, organ transplant procedures and emergency care.